<div><div></div><div>On October 26, 2025, Organon &amp; Co. announced the resignation of Kevin Ali as CEO and Board member amid an investigation. Joseph Morrissey has been appointed as Interim CEO, and Carrie S. Cox as Executive Chair.<div><table><tbody><tr><td>Individual</td><td>Kevin Ali</td><td>Joseph Morrissey</td><td>Carrie S. Cox</td></tr><tr><td>Role</td><td>CEO, Board Member</td><td>Interim CEO</td><td>Executive Chair</td></tr><tr><td>Type of Change</td><td>Resigned</td><td>Appointed</td><td>Appointed</td></tr><tr><td>Effective Date</td><td>Oct 26, 2025</td><td>Oct 26, 2025</td><td>Oct 26, 2025</td></tr><tr><td>Reason</td><td>Investigation</td><td>N/A</td><td>N/A</td></tr><tr><td>Replacement Info</td><td>Joseph Morrissey</td><td>Not disclosed</td><td>Not disclosed</td></tr><tr><td>Background Details</td><td>N/A</td><td>Former EVP, Head of Manufacturing &amp; Supply</td><td>N/A</td></tr><tr><td>Board/Committee Role Changes</td><td>Not disclosed</td><td>Not disclosed</td><td>Not disclosed</td></tr></tbody></table></div>Original SEC Filing: Organon &amp; Co. [ OGN ] - 8-K - Oct. 27, 2025<section>Disclaimer<div>This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.</div></section></div></div>

On October 26, 2025, Organon & Co. announced the resignation of CEO Kevin Ali amid an investigation. Joseph Morrissey has been appointed as Interim CEO, and Carrie S. Cox as Executive Chair, effective the same day. The reasons for Ali's resignation are linked to the ongoing investigation, while details regarding the replacements and committee role changes remain undisclosed.

Organon & Co. Announces CEO Resignation and Interim Appointments